Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - Erenna

  • Biomarkers Take Center Stage
    ... of NYU to show how the use of the Erenna system can provide insights toward ... The Singulex Erenna System has also been applied to cardiovascular disease research, for ...
    5-1-2013
  • Advertorial: Quantifying Low-Abundance TH17 Cytokines to Uncover...
    Here we present case studies demonstrating how the use of the Erenna Immunoassay System ... Digital Single-Molecule Counting Technology Singulex Erenna Immunoassay system utilizes ...
    12-1-2012
  • Designing Assays to Fit the Application
    ... the detection antibody, antigen, and elution buffer remain as a solution to be read in the Erenna immunoassay reader, which is in concept similar to a capillary flow cytometer. ...
    11-1-2012
  • Heterodimer Immunoassay Kit
    The IL-17 immunoassays, designed for use on the Erenna immunoassay system, can detect low levels of biomarkers in blood plasma samples and allow for the measurement of small ...
    6-15-2012
  • MDx Will Drive Personalized Medicine
    Technologies Can Save Healthcare $$$ The Erenna Immunoassay System utilizes a modified ... of R&D. This technology is based on the Erenna(tm) paramagnetic microparticle (MP)-based ...
    4-1-2009
  • Novartis Taps Singulex' Biomarker Detection Platform for Assay...
    Novartis has gained access to Singulex' biomarker detection technology through an Erenna(tm) Technology Access Program (ETAP). The Erenna system has been placed at Novartis' Basel, ...
    3-6-2008
  • Singulex Inks Separate Deals to Enhance the Clinical Utility...
    Scientists at Washington University School of Medicine will join Singulex' Erenna(tm) Technology Access Program. They will thus have access to Erenna, the company's first biomarker ...
    11-15-2007

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Genome Sequencing and Patient Autonomy

Do you think ACMG’s recent recommendations for reporting incidental clinical sequencing results undermine patient autonomy?

Suggest a Poll